2016 Research Year-in-Review: An Historic Year for Our Community
This has been an historic year for the SMA community. On December 23, the FDA announced its approval of Spinraza, the first-ever approved treatment for SMA. In addition to the approval of Spinraza, in 2016 the SMA drug pipeline reached notable highs. There are now: 18 active programs 6 programs in clinical trials 14 pharmaceutical […]
2016 Research Year-in-Review: An Historic Year for Our Community Read More »






